Press releases
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
- Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
More ▼
Key statistics
As of last trade Bicycle Therapeutics PLC (50BA:DUS) traded at 21.80, -2.68% below its post-IPO high of 22.40, set on Apr 19, 2024.
52-week range
Open | 21.80 |
---|---|
High | 21.80 |
Low | 21.80 |
Bid | 21.80 |
Offer | 23.20 |
Previous close | 22.00 |
Average volume | 93.75 |
---|---|
Shares outstanding | 37.97m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 918.81m USD |
EPS (TTM) | -5.13 USD |
Data delayed at least 15 minutes, as of May 02 2024 11:31 BST.
More ▼